A critical breakthrough in cancer study is occurring with the use of VHH fragments to restore mutated p53. This vital tumor inhibitor protein is frequently disabled in many forms of malignancies, causing uncontrolled https://social-lyft.com/story12074974/mini-antibodies-reactivate-the-p53-protein-a-new-approach-for-cancer-treatment